| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.8 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |